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Objectives: Numerous studies have evaluated the association between the apolipo-
protein E (apoE) gene polymorphisms in coronary heart disease (CHD). However, the
results remain uncertain. We carried out a meta-analysis to derive a more compre-
hensive estimation of the association in Chinese population.
Methods: Case-control studies in Chinese and English publications were identiﬁed by
searching databases of PubMed, EMBASE, Web of Science, CNKI, CBM, Wanfang,
VIP and hand searching of relevant journals and the reference lists of retrieved articles.
Odds ratio (OR) and 95% conﬁdence interval (CI) were applied to assess the strength
of the associations. Subgroup analysis and sensitivity analysis were performed to
explore the between-study heterogeneity.
Results: We ﬁnally identiﬁed 61 relevant studies which comprised 6634 case-
patients and 6393 controls. The pooled OR for ε4 carriers was 96% higher than
the ε3/3 genotype for CHD (OR, 1.96; 95% CI 1.70-2.24; P<0.001). However,
there was no evidence of statistically signiﬁcant association between ε2 carriers
and risk of CHD (OR, 1.02; 95% CI 0.91-1.13; P¼0.729). In the subgroup
analysis, different endpoints may partially account for the heterogeneity. No
publication bias was found.
Conclusions: Our meta-analysis suggests that the apoE ε4 allele may be a risk factor
for CHD in the Chinese population, however, ε2 allele has no signiﬁcant
association.GW25-e1413
Early detection of regional and global left ventricular myocardial function using
strain and strain rate imaging evaluation longitudinal strain in patients with
Metabolic syndrome
Wang Qin1, Yang Ya2
1Department of echocardiography in heart center, General hospital of Ningxia
medical university, 2First department of echocardiography, Beijing Anzhen
Hospital, Capital Medical University
Objectives: Strain and strain rate imaging (SRI) has been found clinically useful in
the assessment of cardiac systolic and diastolic function as well as providing new
insights in deciphering cardiac physiology and mechanics in cardiomyopathies, and
identifying early subclinical changes in various pathologies. The aim of this study
was to evaluate the regional and global left ventricular myocardial function in
metabolic syndrome with SRI so that we can provide more myocardial small lesions
in patients with MS, which is robust and reliable basis for early detection of LV
function.
Methods: 39 consecutive adults with metabolic syndrome were enrolled in the study.
There was a control group of 36 healthy adults. In addition to classic echocardio-
graphic assessment of LV global functional changes, SRI was used to evaluate
regional and global left ventricular function. Including: peak systolic strain, peak
systolic strain rate, peak diastolic strain rate.
Results: There were no statistically signiﬁcant differences between MS and con-
trols in all traditional parameters of left ventricular structural and systolic function.
On the other hand, signiﬁcant differences were observed between MS and the
control group in most of the parameters of peak systolic strain (-22.003.88 vs
-27.426.11, P<0.000), peak systolic strain rate (-1.370.39 vs -2.261.16,
P<0.000), peak diastolic strain rate (1.730.68 vs 3.041.11, P<0.000; 1.880.95
vs 1.800.80, P<0.05) in regional left ventricular function. There was no signif-
icant difference in left ventricle (LV) systolic functions measured by conventional
echocardiography between MS and controls. However, there was signiﬁcant
decrease in LV regional function detected by SRI in MS than controls. Multiple
stepwise regression analyses revealed that S and SR signiﬁcantly were negatively
correlated with BP (-0.402, P¼0.002; -0.515, P<0.000), W. Circum(-0.501,
P<0.000; -0.556, P<0.000), FPG (-0.375, P¼0.005; -0.345, P¼0.010), UA
(-0.375, P¼0.005; -0.345, P¼0.001), suggesting that risk factories were relevant to
regional systolic dysfunction.
Conclusions: In ms patients with normal LV ejection fraction (LVEF), risk factories
contributed to the impairment of systolic and diastolic function of the regional
myocardium. The early identiﬁcation of metabolic syndrome by strain and strain rate
may be an indication that aggressive preventive measures should not be postponed
until left ventricular regional function has developed. Especially early left ventricular
regional systolic dysfunction, have to date been sparsely investigated. We present the
ﬁrst demonstration that metabolic syndrome is independently associated with LV
systolic dysfunction. These ﬁndings suggest that assessment of myocardial function
using SRI could be more accurate in MS patient evaluation than conventional echo-
cardiography alone.GW25-e1463
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Objectives: To investigate the relationship between hyperuricemia (HUA) and
sleep apnea hypopnea syndrome (SAHS) in aged patients with cardiovascular
disease.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/EMethods: The patients with SAHS hospitalized due to cardiovascular disease were
divided two groups according to who had hyperuricemia or not. The diagnosis of
SAHS was conﬁrmed by sleep monitoring with micro-movement sensitive
mattress sleep monitoring system. The data of serum uric acid, lipids, uric acid to
creatinine ratio (UA/Cr), and parameters of sleep-disordered breathing were
analyzed.
Results: 106 patients of SAHS were involved this study. There was no differents
in age, sex, hours of sleep, complicated cardiovascular diseases and taken statins
between the two groups. Compared with the control’s, the number of patients
with moderate and severe SAHS [apnea hypopnea index (AHI) equal or more than
15] was more in HUA group, 32/44 vs 33/62, x2¼3.960, P<0.05. The average
AHI in HUA group was higher than that in control’s, P¼0.05, which the increase
of hypopnea index (HI) was mainly contribution to, 10.210.2 vs 6.47.3,
P<0.05. When the patients were grouped according to the real time levels of
serum uric acid, the signiﬁcant dicrease of nocturnal lowest saturation of blood
oxygen was found in the real time HUA group, (75.88.6) % vs (79.46.7) %,
P<0.05. Analyses of blood lipids showed that the level of serum high-density
lipoprotein cholesterol (HDL-C) was lower and the level of triacylglycerol (TG)
was higher in HUA group than that in the control’s, but no signiﬁcance in the
latter. The level of serum uric acid was negatively correlated with HDL-C and
positvely correlated with TG, r¼-0.305, P<0.01, r¼0.237, P<0.05, individually.
The UA/Cr in HUA group was higher than that in the control’s, but nevertheless
no correlation was found between UA/Cr and any parameter of sleep-breathing
disordered.
Conclusions: The patients of SAHS complicated HUA has more serious sleep-
breathing disordered and abnormal lipid metabolism than those with normal level
of serum uric acid. HUA is correlated with nocturnal hypoxemia. The further
research is needed to ﬁnd out whether a relation existed between UA/Cr and tissue
hypoxia.
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Objectives: The present study aimed to investigate the best single predictor of
metabolic syndrome (MetS) according to compare predicting ability of various
anthropometric and atherogenic parameters among Kazakh population in Xinjiang,
northwest of China.
Methods: 4094 Kazakh participants were recruited from the Cardiovascular Risk
Survey (CRS) which was carried out from October 2007 to March 2010. Anthro-
pometric data, blood pressure, concentrations of serum total cholesterol (TC), tri-
glyceride (TG), low density lipoprotein cholesterol (LDL-C), high density
lipoprotein cholesterol (HDL-C) and fasting plasma glucose (FPG) were docu-
mented. Prevalence of MetS and its individual components were conﬁrmed ac-
cording to IDF criteria. Area under the receiver’s operating characteristic curve
(AUC) of each variable for the presence of MetS was compared. The sensitivity
(Sen), speciﬁcity (Spe), shortest distance in the receiver’s operating characteristic
curve (ROC) and cutoffs of each variable for the diagnosis of MetS were
calculated.
Results: 28.6% of men had the MetS and 31.0% of women had the MetS in Kazakh
population in Xinjiang. In men, the WHtR had the highest AUC value (AUC¼0.821),
it was followed by BMI (AUC¼0.801), TG/HDL-C (AUC¼0.792), WHR
(AUC¼0.776) and BAI (AUC¼0.666). In women, the WHtR also had the highest
AUC value (AUC¼0.835), it was followed by BMI (AUC¼0.789), WHR
(AUC¼0.778), TG/HDL-C (AUC¼0.778) and BAI (AUC¼0.751). Similarly, among
all 5 anthropometric and atherogenic parameters, the WHtR had the shortest ROC
distance of 0.37 (Sen¼81.09%, Spe¼68.50%), the optimal cutoff for WHtR was 0.55
in men. In women, WHtR also had the shortest ROC distance of 0.35 (Sen¼84.59%,
Spe¼68.97%), the optimal cutoff of WHtR was 0.54.
Conclusions: WHtR was the best predictor of metabolic syndrome in both Kazakh
men and women in Xinjiang.
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Objectives: To investigate the predictive value of arterial stiffness index estimation
for adverse cardiac events.
Methods: A total of 198 patients with risk factors of coronary artery disease (CAD)
underwent two noninvasive tests of arterial stiffness at least two times in 5 years,
including pulse wave analysis (PWA) and carotid ultrasonography, and were divided
into increased arterial stiffness (IAS) group (n¼87) and control group (n¼111), by
central pulse pressure higher than 45 mmHg or not during follow-up. Adverse cardiacpidemiology, Prevention and Control C111
events were compared between two groups, and independent predictors of prognosis
were also identiﬁed.
Results: Compared with patients in control group, those in IAS group had higher
ratio of hypertension (P<0.05). During follow-up (mean 5212 months), 42 cases
of end point events were recorded, including 20 major adverse cardiac events
(MACE). The rate of MACE (IAS group vs control group, 18.4% vs 3.6%,
RR¼6.03, 95% CI 1.94-18.77, P¼0.001) and end point events (33.3% vs 11.7%,
RR¼3.79, 95% CI 1.82-7.82, P<0.001) were signiﬁcantly higher in IAS group.
Multivariate Cox regression analysis revealed that CPP>45 mmHg (RR¼3.86,
95% CI 1.89-7.87, P<0.001), common carotid atherosclerotic plaque (RR¼2.17,
95% CI 1.38-3.41, P¼0.001), multivessel CAD (RR¼1.70, 95% CI1.24-2.34,
P¼0.001) and a prior history of cerebral vascular disease (RR¼3.26, 95% CI1.41-
7.52, P¼0.006) were independent predictors of prognosis of cardiovascular
diseases.
Conclusions: CPP >45mmHg and common carotid atherosclerotic plaque were in-
dependent predictors of adverse cardiac events. The results indicated a high value of
noninvasive arterial stiffness index estimation for prognosis.
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Effect of the combined increase of C-reactive protein and uric acid level on
metabolic syndrome and its components
Zhu Wenhua, Fang Lizheng, Chen Jianhua, Chen Yan, Chen Liying
Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Objectives: The combined effect of C-reactive protein (hs-CRP) and uric acid on
progression of metabolic syndrome (MS) is inadequately deﬁned. The aim of this
study is to evaluate the effect of the combined increase of high-sensitivity
C-reactive protein (hs-CRP) and uric acid (UA) on metabolic syndrome and its
components.
Methods: A total of 21936 subjects who took well-man or -woman check up in our
hospital were enrolled. Hs-CRP, uric acid, fasting plasma glucose, lipid proﬁle, waist
circumference and blood pressure were measured to analyze the relationship between
metabolic syndrome and its components with hs-CRP and uric acid in three groups
(low-risk group: hs-CRP<1 md/dL, mid-risk group: hs-CRP 1w3 md/dL, high-risk
group: hs-CRP>3 md/dL).
Results: (1) As hs-CRP values increased, waist circumference, uric acid, tri-
glycerides, fasting plasma glucose, systolic blood pressure, diastolic blood pressure
and high-density lipoprotein increased among the three groups. F values were 86.38,
41.11, 23.37, 18.56, 19.22, 17.88 and 12.23 separately (P<0.01). (2) Mid and high-
risk groups of hs-CRP with hyperuricemia were closely related to waist circumfer-
ence, triglycerides and systolic blood pressure. OR values were 3.26, 3.27, 1.59 and
3.77, 3.38, 1.64 separately (P<0.05). (3) The incidence of metabolic syndrome
increased gradually with the combined increases of hs-CRP and uric acid, they were
49.06% and 55.59% in the mid and high-risk groups of hs-CRP with hyperuricemia
(P<0.01).
Conclusions: With increased values of both hs-CRP and uric acid, metabolic dis-
orders tended to be worse and the incidence of metabolic syndrome was increased.
Hs-CRP and uric acid can be used as a clinical predicting or monitoring item
for MS.
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Objectives: The effect of tea intake on blood pressure (BP) is controversial. We
undertook a meta-analysis of randomized controlled trials to determine changes in
systolic and diastolic BP due to the intake black and green tea.
Methods: MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were
searched from 1966 until January 2014 for studies in parallel group or crossover
design in which BP was assessed before and after receiving black or green tea for at
least 1 week. The weighted mean difference was calculated for net changes in BP by
using ﬁxed-effects or random-effects models. Previously deﬁned subgroup analyses
were performed to explore the inﬂuence of study characteristics.
Results: 21 eligible randomized controlled trials with 1323 subjects were enrolled.
After the tea intake, the pooled mean systolic and diastolic BP were 1.8 mmHg
(95% conﬁdence interval [CI], 2.4- 1.1 mmHg) and 1.4mmHg (95% CI, 2.2-
0.6 mm Hg) lower, respectively, compared with the tea-free controls. Subgroup
analyses showed that the BP-lowering effect was apparent in the subjects who
consumed a tea over a median of 12 weeks (systolic/diastolic BP, -2.6/-2.1 mmHg,
both P <0.001). Stratiﬁed by type of tea, green tea signiﬁcantly reduced systolic and
diastolic BP of -2.1 (95% CI, 2.9- 1.2) and -1.7 (95% CI, 2.9- 0.5) mm Hg,
and black tea signiﬁcantly reduced systolic and diastolic BP of -1.4 (95% CI, 2.4-
0.4) and -1.1 (95% CI, -1.9- 0.2) mm Hg, respectively. The beneﬁts of tea intake
were not inﬂuenced by ethnicity, treatment dose of tea catechins, individual health
status, or caffeine intake.
Conclusions: The meta-analysis showed that long-term (12 weeks) ingestion
of a tea (green and black tea) resulted in a signiﬁcant reduction in systolic and
diastolic BP.C112 JACC Vol 64/16/Suppl C j October 16Diabetes
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Objectives: Musclin is a skeletal muscle-derived secretory factor discovered in
2004. A limited number of studies have addressed the relationship between
musclin levels and the alterations of endogenous musclin in type 2 diabetes mel-
litus (T2DM). To ﬁll this blank, this study examined the changes of musclin levels
in plasma and therefore indicated the association between musclin levels and
T2DM.
Methods: In this hospital-based case-control study, 38 newly diagnosed T2DM
subjects who never received anti-diabetic therapy, 41 T2DM subjects under insulin
treatment were enrolled from outpatient department of the Second Afﬁliated Hos-
pital of Harbin Medical University, and the 41 normal subjects with no medical
history were recruited from the health check-up population of our hospital. Fasting
plasma glucose (FPG), serum insulin, hemoglobin A1c (HbA1c) and blood lipid
proﬁle were determined using commercially available diagnostic reagents at the
clinical biochemical laboratories. Plasma musclin levels were measured by
radioimmunoassay.
Results: Plasma musclin levels were signiﬁcantly higher in the newly diagnosed
T2DM group compared with the normal group (83.0716.16 ng/L vs 93.1815.50
ng/L, P <0.01) and were signiﬁcantly decreased in T2DM patients with insulin
therapy (93.1815.50 ng/L vs 83.7419.12 ng/L, P<0.05). Musclin levels in
plasma of newly diagnosed T2DM patients were positively correlated with FPG
(r¼0.467, P<0.01), HbA1c (r¼0.383, P<0.05), serum insulin (r¼0.551, P<0.01),
triglycerides (r¼0.452, P<0.01) and homeostasis model assessment of insulin
resistance (HOMA-IR) (r¼0.388, P<0.05). High-density lipoprotein cholesterol
(HDL-C) levels were negatively correlated with musclin levels (r¼-0.339,
P<0.05).
Conclusions: An upregulation of plasma musclin level increase the risk of T2DM.
There might be a connection between musclin and the pathogenesis of T2DM.
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Objectives: The atherosclerosis risk in communities (ARIC) study have demonstrated
that lower heart rate variability (HRV) is associated with the development of coronary
heart disease (CAD) in individuals with diabetes. However, the relationship between
blood glucose variability and HRV remains unclear. The present study aimed to
explore the impact of glucose variability on HRV in patients with type 2 diabetes
mellitus (T2DM).
Methods: According to glucose variability, assessed by mean amplitude of gly-
cemic excursions (MAGE) obtained from continuous glucose monitoring sys-
tem(CGMS), 68 consecutive type 2 diabetic patients without CAD were divided
into two groups: subjects with non-glucose ﬂuctuation (MAGE<3.9 mmol/l,
n¼32) and subjects with glucose ﬂuctuation (MAGE>¼3.9mmol/l, n¼36). Thirty
healthy controls (NC) were also enrolled. HRV was assessed by dynamic elec-
trocardiogram examination. HRV analysis included time domain parameters such
as SDNN, SDANN, rMSSD and pNN50, and total spectral power (TP) of HRV,
which mainly consists of VLF, LF and HF component along with LF/HF ratio, was
also obtained.
Results: Compared with NC, all the time domain measures were signiﬁcantly lower
in T2DM (SDNN: 92.2.823.1 vs 121.727.4, P<0.05; SDANN: 78.722.9 vs
106.222.5, P<0.05; rMSSD: 27.510.2 vs 35.710.1, P<0.05; and pNN50:
6.07.1 vs 8.87.8, P<0.05). For frequency domain, LF and HF were signiﬁcantly
lower in T2DM (LF:300.2237.8 vs 398.7277.5, P<0.05; HF: 141.8121.5 vs
186.5171.5, P<0.05) whereas VLF and LF/HF ratio were comparable (P>0.05). In
cases with glucose ﬂuctuation, SDNN(79.122.1 vs 100.824.1, P<0.05), SDANN
(61.323.8 vs 88.720.9, P<0.05), rMSSD (23.110.5 vs 29.311.5, P<0.05),
PNN50 (4.96.6 vs 6.56.1, P<0.05), TP (1290.8902.3 vs 1727.01131.5,
P<0.05) and HF (102.1110.7 vs 139.8122.4, P<0.05) were all signiﬁcantly
lower than those in non-glucose ﬂuctuation subjects. No signiﬁcant differences in
VLF (1190.4861.6 vs 1285.6858.0, P>0.05) and LF (274.9223.0 vs–19, 2014 j GW-ICC Abstracts/Epidemiology, Prevention and Control
